New Zealand Medical & Scientific represent Pierre Fabre Medicament a leading research based company in the area of oncology. The principle product developed by Pierre Fabre is Navelbine® (vinorelbine tartrate) a unique product which offers many advantages for people suffering from metastatic breast cancer and/or non-small cell lung cancer. Ongoing research into this product will mean that more people suffering from various cancers can experience the many benefits of therapy with Navelbine®